KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) FCF Payout Ratio (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.13%
Dec 31, 2025 342.38%
Sep 30, 2025 -54.94%
Jun 30, 2025 -48.68%
Mar 31, 2025 376.55%
Dec 31, 2024 -24.99%
Sep 30, 2024 -32.93%
Jun 30, 2024 -79.32%
Mar 31, 2024 -33.28%
Dec 31, 2023 769.20%
Sep 30, 2023 52.92%
Jun 30, 2023 -81.21%
Mar 31, 2023 250.61%
Dec 31, 2022 22.28%
Sep 30, 2022 -40.24%
Jun 30, 2022 12.66%
Mar 31, 2022 39.32%
Dec 31, 2021 -14.46%
Sep 30, 2021 -20.48%
Jun 30, 2021 10.12%
Mar 31, 2021 11.38%
Dec 31, 2020 62.59%
Sep 30, 2020 -17.51%
Jun 30, 2020 -26.02%
Mar 31, 2020 28.31%
Dec 31, 2019 36.61%
Sep 30, 2019 -60.94%
Jun 30, 2019 32.97%
Mar 31, 2019 84.19%
Dec 31, 2018 3.13%
Sep 30, 2018 -39.26%
Jun 30, 2018 22.16%
Mar 31, 2018 26.75%
Dec 31, 2017 14.73%
Sep 30, 2017 -35.66%
Jun 30, 2017 3.43%
Mar 31, 2017 46.94%
Dec 31, 2016 -13.16%
Sep 30, 2016 -0.90%
Jun 30, 2016 -29.33%
Mar 31, 2016 33.99%
Dec 31, 2015 46.69%
Sep 30, 2015 13.85%
Jun 30, 2015 -56.50%
Mar 31, 2015 149.77%
Dec 31, 2014 -2.58%
Sep 30, 2014 -19.94%
Jun 30, 2014 -52.47%
Mar 31, 2014 118.89%
Dec 31, 2013 -0.12%
Sep 30, 2013 -11.70%
Jun 30, 2013 -37.99%
Mar 31, 2013 -11.51%
Dec 31, 2012 148.73%
Sep 30, 2012 41.62%
Jun 30, 2012 -63.07%
Mar 31, 2012 91.07%
Dec 31, 2011 -40.02%